Duodenal and jejunal Dieulafoy's lesions: optimal management

Creative Commons License

Yılmaz T. U., Kozan R.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, vol.10, pp.275-283, 2017 (ESCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 10
  • Publication Date: 2017
  • Doi Number: 10.2147/ceg.s122784
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.275-283
  • Keywords: Dieulafoy's lesion, gastrointestinal bleeding, duodenum, endoscopy, SMALL-BOWEL, ENDOSCOPIC TREATMENT, DIAGNOSIS, MALFORMATION, EXPERIENCE, ANEURYSM, EFFICACY, OUTCOMES, DISEASE
  • Gazi University Affiliated: Yes


: Dieulafoy’s lesions (DLs) are rare and cause gastrointestinal bleeding resulting from erosion of dilated submucosal vessels. The most common location for DL is the stomach, followed by duodenum. There is little information about duodenal and jejunal DLs. Challenges for diagnosis and treatment of Dieulafoy’s lesions include the rare nature of the disease, asymptomatic patients, bleeding symptoms often requiring rapid diagnosis and treatment in symptomatic patients, variability in the diagnosis and treatment methods resulting from different lesion locations, and the risk of re-bleeding. For these reasons, there is no universal consensus about the diagnosis and treatment approach. There are few published case reports and case series recently published. Most duodenal DLs are not evaluated seperately in the studies, which makes it difficult to determine the optimal model. In this study, we summarize the general aspects and recent approaches used to treat duodenal DL.